Search by Drug Name or NDC
NDC 45963-0607-56 Vinorelbine 10 mg/mL Details
Vinorelbine 10 mg/mL
Vinorelbine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is VINORELBINE TARTRATE.
MedlinePlus Drug Summary
Vinorelbine is used alone and in combination with other medications to treat non-small cell lung cancer (NSCLC) that has spread to nearby tissues or to other parts of the body. Vinorelbine is in a class of medications called vinca alkaloids. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 45963-0607-56Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Vinorelbine Injection
Product Information
NDC | 45963-0607 |
---|---|
Product ID | 45963-607_1a467892-817b-4ff8-a58e-b69e0c3462cc |
Associated GPIs | 21500050802020 21500050802025 |
GCN Sequence Number | 022552 |
GCN Sequence Number Description | vinorelbine tartrate VIAL 10 MG/ML INTRAVEN |
HIC3 | V1C |
HIC3 Description | ANTINEOPLASTIC - VINCA ALKALOIDS |
GCN | 38580 |
HICL Sequence Number | 009614 |
HICL Sequence Number Description | VINORELBINE TARTRATE |
Brand/Generic | Generic |
Proprietary Name | Vinorelbine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Vinorelbine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 10 |
Active Ingredient Units | mg/mL |
Substance Name | VINORELBINE TARTRATE |
Labeler Name | Actavis Pharma, Inc. |
Pharmaceutical Class | Vinca Alkaloid [EPC], Vinca Alkaloids [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078011 |
Listing Certified Through | 2024-12-31 |
Package
NDC 45963-0607-56 (45963060756)
NDC Package Code | 45963-607-56 |
---|---|
Billing NDC | 45963060756 |
Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-607-56) / 5 mL in 1 VIAL, SINGLE-DOSE |
Marketing Start Date | 2015-03-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |